Finance Manager Oncology BU

3310 Takeda Pharmaceuticals U.•Boston, MA

1d•Onsite

About The Position

Serve as a finance business partner to key US OBU functions, including Sales, Insights & Analytics, and Strategy & Business Operations, helping translate business priorities into clear financial plans, resource choices, and decision support. Support both Solid Tumor and Hematology franchises by providing financial insight, cross-functional partnership, and performance management that enables informed portfolio and franchise decisions. Partner with functional and franchise leaders during planning cycles, including MRP, MYC, long-range planning, rolling forecasts, and monthly performance management, to align investment levels with business strategy and expected impact. Provide analytical support, financial storytelling, and scenario-based recommendations that improve transparency, strengthen business accountability, and support disciplined decision making across the US OBU.

Requirements

Bachelor’s degree required, preferably in Finance or Accounting
4-7 years of experience in financial planning and analysis, business partnering, reporting, budgeting, forecasting, OpEx management, or related finance roles.
Strong proficiency in Microsoft Excel and PowerPoint, including advanced financial modeling and the ability to develop executive‑ready presentations.

Nice To Haves

MBA or MSF desirable.
Experience in pharmaceuticals/biotech and/or multinational organizations preferred.
Experience with planning and reporting systems such as Anaplan, TM1, Hyperion, or similar financial planning tools preferred.
Experience with SAP is desirable.
People management experience is desirable but not required; demonstrated ability to coach junior colleagues, manage workstreams, and influence cross-functional partners is preferred.

Responsibilities

Act as the finance business partner for assigned US OBU functions, including Sales, Insights & Analytics, and Strategy & Business Operations, building strong relationships with business stakeholders and providing proactive financial guidance.
Support both Solid Tumor and Hematology franchises by connecting functional investment decisions to franchise priorities, portfolio performance, and longer-term business objectives.
Support financial planning and forecasting support for assigned functions and franchise areas, working with business partners to align assumptions, evaluate risks and opportunities, and ensure submissions reflect strategic priorities.
Prepare clear financial narratives, insights, and recommendations for monthly and quarterly business reviews, helping leaders understand performance drivers, trade-offs, and investment implications.
Partner with Sales, Insights & Analytics, and Strategy & Business Operations to evaluate resource allocation, initiative funding, field-facing investments, analytics needs, and business operations priorities across both franchises.
Build and enhance financial models, dashboards, and analytical tools that support franchise planning, scenario analysis, investment prioritization, and management reporting across the US OBU.
Monitor key business and financial indicators, identify trends, and assess underlying drivers to enable fact-based decisions within a complex and investment-sensitive oncology portfolio.
Support core FP&A processes, including functional OpEx management, personnel planning, accrual coordination, and Anaplan forecasting, while positioning these activities as enablers of stronger business partnership and decision quality.